Rheumatology Winter Clinical Symposium

Home
United States
Kihei, HI
Rheumatology Winter Clinical Symposium

The premier international academic rheumatology conference. Follow us for news and clinical pearls on RA, SLE, PsA and more autoimmune conditions!

Rheumatology Winter Clinical Symposium (RWCS) is a leader in the most up-to-date education in Rheumatology. Our faculty are world-renowned experts in the fields of Rheumatology and musculoskeletal disease.

02/27/2026

Do you have a rheumatology question or case for Dr. Cush? Record it today and you might be featured in an upcoming podcast episode!

Record a Question or Comment...Have a Rheumatology question or case for Jack Cush? Record it here, and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.

02/24/2026

A Canadian cohort study on giant cell arteritis shows relapse in nearly half of patients, often after stopping treatment, and methotrexate didn’t significantly reduce that risk. Read more

A retrospective cohort study of patients with giant cell arteritis (GCA) demonstrates relapses are common and seen in nearly half of patients, were common after treatment is stopped and is not effectively averted by methotrexate (MTX).

02/21/2026

The ALTO study, now published in Lancet Rheumatology, shows abatacept can delay progression to RA for up to 4 years in at-risk patients—marking a major step in RA prevention strategy. Read more

Lancet Rheumatology has published the ALTO results - long term outcomes of the APIPPRA trial, demonstrating that treatment with abatacept (ABA) in at risk patients can delay progression to rheumatoid arthritis (RA) for up to 4 years.

02/19/2026

At RNL26, Dr. Jeffrey Sparks delivered a state-of-the-art update on RA-ILD, highlighting recent advances in understanding and treatment, many driven by his own research group. Read more:

Dr. Jeffrey Sparks gave a state of the art update on Advances in RA-ILD, many of which he and his group have played a big part in, on Saturday at RNL26.

02/16/2026

At RheumNow Live, Pod IV tackled “Staying Ahead of Spondyloarthritis”—covering diagnosis, complications, and new advances in SpA care. Read more:

The diagnosis and treatment of spondyloarthritis can present challenging clinical scenarios for rheumatologists. At RheumNow Live, Pod IV focused on "Staying Ahead of Spondyloarthritis", which reviewed diagnosis, complications and advances in SpA.

02/14/2026

The American College of Physicians has released a new ethics position paper urging the end of the term "provider" for physicians, arguing it diminishes professionalism, clinical integrity, and ethical responsibility. Read more:

With apologies to Shakespeare, names are important. In health care, they can have ethical significance. The American College of Physicians has published a new ethics/position policy paper proclaiming that the term ‘provider’ should not be used to describe physicians, and using the blanket term u...

02/11/2026

Sunday’s vasculitis session at RNL26 featured updates on small and large vessel inflammation from Dr. Mike Putman and Dr. Clay Cockerell—covering diagnosis, pathology, and treatment pearls. Read more

Sunday’s vasculitis session at RNL26 was a fantastic update on inflamed blood vessels, large and small, by two experts in the field: rheumatologist Dr. Mike Putman and dermatopathologist Dr. Clay Cockerell.

02/09/2026

The FDA has asked Amgen to voluntarily withdraw avacopan (Tavneos) for ANCA-associated vasculitis. Amgen has declined, saying it will keep the drug on the market.

The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, but the company said it has no plans to pull the drug from the market.Originally developed by ChemoCentryx, the oral complement 5a inhibito...

01/31/2026

The TULIP-SC trial shows weekly subcutaneous anifrolumab delivers similar efficacy and safety to IV in patients with severe SLE. Read more:

Manzi et al. have published the results of the TULIP-SC trial that showed that weekly subcutaneous (SC) anifrolumab, when given to severe SLE patients, had comparable efficacy and safety to the approved intravenous (IV) anifrolumab. TULIP-SC was a phase 3, double-blind, placebo-controlled to evaluat...

01/29/2026

A real-world study of >500 children across 5 countries compared acitretin, cyclosporine, and methotrexate in pediatric psoriasis. MTX and acitretin showed better 2-year survival than cyclosporine. Dr. Jason Hawkes shares expert insight on what this means:

Jason Hawkes provides expert commentary on an international multicenter study evaluating two-year drug survival, efficacy, and safety of acitretin, cyclosporine, and methotrexate in pediatric psoriasis patients.

01/26/2026

In rheumatic disease patients with diffuse alveolar hemorrhage (DAH), a new study highlights high rates of coexisting pulmonary infection and elevated mortality risk. Read more:

A retrospective, cross-sectional, single-center study of adult rheumatic disease patients with diffuse alveolar hemorrhage (DAH), demonstrates a high proportion have coexistent pulmonary infection and significant mortality risk. DAH is an uncommon but potentially life-threatening pulmonary complicat...

Address

Kihei, HI
96753

Website

http://www.r-w-c-s.com/

Alerts

Be the first to know and let us send you an email when Rheumatology Winter Clinical Symposium posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rheumatology Winter Clinical Symposium:

Shortcuts

Want your practice to be the top-listed Clinic in Kihei?